Saturday, September 5, 2026
29.9
C
Bengaluru
Hot topics
Careers in Medical Device Companies
Key Insights
Thermo Fisher Scientific leads the industry with $42.88 billion...
Making Peace with an Unlived Life – My Journey by Deep Bhandari
The Beginning
I was at crossroads after completing computer...
Crafting a Digital Strategy
A Digital-in-pharma special issue. Announcement for ACG-MedicinMan's "Pharmaceutical Marketing in the New Age" conference to be held in March 2018
Violence Against Doctors: Doctor-Patient Relationship Bruised and Battered
If a business fails, it was an idea that didn’t work. If treatment fails – it must be a botch up. A broken gadget may be beyond repair, but not a patient in a doctor’s hands. From such ungraded expectations stems the potential for things to take an ugly turn.
An unwanted profession dealing with an unwanted condition, namely Ill health:
If possible, we would wish away death and diseases, hospitals and doctors. A hospital is not a holiday resort, but it too costs money. And the scenario of an adverse outcome like death simply becomes unacceptable.
IPM Powers Ahead in 2026: 11% Growth Fueled by Cardiac, Anti-Diabetics, and GLP-1 Stars
India's pharmaceutical market charged into 2026 with strong momentum,...
RPG-Raghava and Lessons From a Decade of Indian Pharma M&A
RPG Active Pharma’s agreement to acquire the API and...
Pharmacy of the World Pricing Paradox
India occupies an extraordinary position in global pharmaceuticals. It...
Why The Government Must Stop Playing Market Trader And Start Being The Sheriff
India has two very different pharmaceutical regulators living inside...
GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?
STOP PRESS
August 10, 2026: Regulatory Authorisation — The UK...
RPG-Raghava and Lessons From a Decade of Indian Pharma M&A
RPG Active Pharma’s agreement to acquire the API and...
Pharmacy of the World Pricing Paradox
India occupies an extraordinary position in global pharmaceuticals. It...
Why The Government Must Stop Playing Market Trader And Start Being The Sheriff
India has two very different pharmaceutical regulators living inside...
GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?
STOP PRESS
August 10, 2026: Regulatory Authorisation — The UK...
RPG-Raghava and Lessons From a Decade of Indian Pharma M&A
RPG Active Pharma’s agreement to acquire the API and...
Pharmacy of the World Pricing Paradox
India occupies an extraordinary position in global pharmaceuticals. It...
Why The Government Must Stop Playing Market Trader And Start Being The Sheriff
India has two very different pharmaceutical regulators living inside...
GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?
STOP PRESS
August 10, 2026: Regulatory Authorisation — The UK...
RPG-Raghava and Lessons From a Decade of Indian Pharma M&A
RPG Active Pharma’s agreement to acquire the API and...
Pharmacy of the World Pricing Paradox
India occupies an extraordinary position in global pharmaceuticals. It...
Why The Government Must Stop Playing Market Trader And Start Being The Sheriff
India has two very different pharmaceutical regulators living inside...
GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?
STOP PRESS
August 10, 2026: Regulatory Authorisation — The UK...
Hot topics
7 Ways to Increase Productivity of Pharma Sales Reps
With access to HCPs becoming a daunting task for...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Pharm-Uneasy As Leadership Changes Take Effect
India’s digital health landscape saw a significant leadership change...
Why and How Can Pharma Make the Shift from Product Centricity to Customer Centricity?
The customer is the one who buys a product...
Specially Designed Case Study based Modules for Pharma Marketing Professionals
More than digitalizing your product promotions, the case calls for building and engaging your brand community through digital solutions that create memorable customer experiences.
With the new normal emerging, the traditional Pharma commercial model needs to be relooked by exploring alternative channels of engagement, which offer opportunities to create value for customers.
Company-specific digital adoption workshops to experience how a brand can be promoted using the omnichannel approach with field force involvement.
RPG-Raghava and Lessons From a Decade of Indian Pharma M&A
RPG Active Pharma’s agreement to acquire the API and...
Pharmacy of the World Pricing Paradox
India occupies an extraordinary position in global pharmaceuticals. It...
Why The Government Must Stop Playing Market Trader And Start Being The Sheriff
India has two very different pharmaceutical regulators living inside...
GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?
STOP PRESS
August 10, 2026: Regulatory Authorisation — The UK...
RPG-Raghava and Lessons From a Decade of Indian Pharma M&A
RPG Active Pharma’s agreement to acquire the API and...
Pharmacy of the World Pricing Paradox
India occupies an extraordinary position in global pharmaceuticals. It...
Why The Government Must Stop Playing Market Trader And Start Being The Sheriff
India has two very different pharmaceutical regulators living inside...
GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?
STOP PRESS
August 10, 2026: Regulatory Authorisation — The UK...
RPG-Raghava and Lessons From a Decade of Indian Pharma M&A
RPG Active Pharma’s agreement to acquire the API and...
Pharmacy of the World Pricing Paradox
India occupies an extraordinary position in global pharmaceuticals. It...
Why The Government Must Stop Playing Market Trader And Start Being The Sheriff
India has two very different pharmaceutical regulators living inside...
GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?
STOP PRESS
August 10, 2026: Regulatory Authorisation — The UK...
RPG-Raghava and Lessons From a Decade of Indian Pharma M&A
RPG Active Pharma’s agreement to acquire the API and...
Pharmacy of the World Pricing Paradox
India occupies an extraordinary position in global pharmaceuticals. It...
Why The Government Must Stop Playing Market Trader And Start Being The Sheriff
India has two very different pharmaceutical regulators living inside...
GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?
STOP PRESS
August 10, 2026: Regulatory Authorisation — The UK...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
RPG-Raghava and Lessons From a Decade of Indian Pharma M&A
RPG Active Pharma’s agreement to acquire the API and...
Pharmacy of the World Pricing Paradox
India occupies an extraordinary position in global pharmaceuticals. It...
Why The Government Must Stop Playing Market Trader And Start Being The Sheriff
India has two very different pharmaceutical regulators living inside...
Newsletter
Get important news delivered directly to your inbox and stay connected!